IMC Chicago’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
IMC Chicago's ADMA Position: Q3 2026 in Review
IMC Chicago increased its ADMA Biologics (ADMA) stake by 37% in Q3 2026, buying an estimated $151K and bringing the position to 60,382 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #4667.
IMC Chicago first reported a position in ADMA in Q2 2025 and has held it in 6 quarters since. 329 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- IMC Chicago held 60,382 shares of ADMA Biologics worth $606K as of Q3 2026.
- IMC Chicago bought 16,290 ADMA Biologics shares in Q3 2026, an estimated $151K.
- ADMA Biologics made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4667 holding.
- IMC Chicago first reported a position in ADMA Biologics in Q2 2025 and has held it in 6 quarters since.
- 329 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.